Header Logo

Connection

Michael Liptay to Dose-Response Relationship, Drug

Back to Details
This is a "connection" page, showing publications Michael Liptay has written about Dose-Response Relationship, Drug.
Michael Liptay
Connection Strength
0.015
Dose-Response Relationship, Drug
  1. A phase I/II trial of induction chemotherapy with carboplatin and gemcitabine followed by concurrent vinorelbine and paclitaxel with chest radiation in patients with stage III non-small cell lung cancer. Lung Cancer. 2004 Aug; 45(2):243-53.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.